LuciErda 5 mg Tablet
Prescription Required
Brand Name:
LuciErda
Molecule:
ErdafitinibStrength:
5 mg
Quantity:
28 Tablets
Form:
Tablet
Packaging Type:
Bottle
Manufacturer/Marketed By:
Lucius PharmaCountry of Origin:
Laos
Enquiry Form
No similar products found.
Description
LuciErda 5 mg Tablet is a kinase inhibitor approved for treating adults with locally advanced or metastatic urothelial carcinoma (mUC) with susceptible FGFR3 or FGFR2 genetic alterations. It is indicated for patients who have progressed after prior platinum-containing chemotherapy, including neoadjuvant or adjuvant therapy within the last 12 months. Before starting LuciErda treatment, it is essential to confirm the presence of FGFR genetic alterations in tumor specimens. The recommended initial dosage of LuciErda is 8 mg orally once daily, with a potential increase to 9 mg daily based on specified criteria.
Related Products
Lucirux Ruxolitinib 5 mg Tablet
Molecule: Ruxolitinib
Manufacturer: Lucius Pharma
Ask for Price
Enquiry Form
Related Posts:
No matching posts found.
Reviews
Clear filtersThere are no reviews yet.